In conclusion, this study integrates computational biology and experimental validation to demonstrate that ICT potentially inhibits tumor progression and holds prognostic significance in HCC by modulating a novel network of core targets—CA9, UCK2, FABP5, and CYP2C9—thereby influencing key oncogenic pathways, including the cell cycle and metabolic regulation. This evidence concerns the gene FABP5 and hepatocellular carcinoma.